IMRX
IMRX
NASDAQ · Biotechnology

Immuneering Corp - Class A

Small-Cap Stocks Stocks Under $10 Biotech Stocks Healthcare Stocks
$5.02
+0.16 (+3.29%)
As of Mar 22, 10:28 PM ET ·
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Buy 11 92%
Hold 1 8%
Sell 0 0%
Price Target
Analyst Price Target -29.5% upside
Low Target $2.50
Average Target $3.54
High Target $3.55
Current Price $5.02
Current
$5.02
Target
$3.54
$2.50 $3.54 avg $3.55
Scenario Analysis
Bear Case
$2.50
-50.2%
Low target
Base Case
$3.54
-29.5%
Avg target
Bull Case
$3.55
+-29.3%
High target
Risk/Reward
0.6x
Unfavorable
Price in Context
52-Week High
$3.33
50.8% from high
52-Week Low
$1.38
+263.8% from low
Target vs 52W High
$3.54
+6.3% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Buy 39 69% $257.58 +24.3%
AMGN
Amgen Inc
 Hold 42 50% $190.87 -46.1%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +162.3%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 -3.7%
REGN
Regeneron Pharmaceuticals
 Strong Buy 36 75% $76.80 -89.8%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
 Strong Buy 26 92% $143.40 -3.3%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -27.6%